RESTENOSIS PATTERN OF SECOND-GENERATION DRUG-ELUTING STENT

Methods: From January 2012 to March 2014, 1835 consecutive patients were treated with Platinum Chromium everolimus-eluting stent (PtCr EES: 1392 lesions), Cobalt Chromium everolimus-eluting stent (CoCr EES: 1232 lesions), and biolimus-eluting stent (BES: 1132 lesions), and underwent midterm follow-u...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2015-03, Vol.65 (10), p.A1827-A1827
Main Authors: Ichinohe, Tahei, Kadota, Kazushige, Shimada, Takenobu, Amano, Hidewo, Izawa, Yu, Kanazawa, Takenori, Kubo, Shunsuke, Miyake, Koshi, Ohashi, Noriyuki, Hayakawa, Yuki, Hasegawa, Daiji, Otsuru, Suguru, Habara, Seiji, Tanaka, Hiroyuki, Tada, Takeshi, Fuku, Yasushi, Katoh, Harumi, Goto, Tsuyoshi, Mitsudo, Kazuaki
Format: Article
Language:English
Subjects:
Angioplasty
Cardiology
Cardiovascular
Internal Medicine
Stents
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Methods: From January 2012 to March 2014, 1835 consecutive patients were treated with Platinum Chromium everolimus-eluting stent (PtCr EES: 1392 lesions), Cobalt Chromium everolimus-eluting stent (CoCr EES: 1232 lesions), and biolimus-eluting stent (BES: 1132 lesions), and underwent midterm follow-up coronary angiography (f/u CAG) at 8 months after implantation.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(15)61827-7